Efficacy and safety of anti-VEGF/VEGFR monotherapy and combination with immune checkpoint inhibitors for advanced or metastatic renal cell carcinoma: a network meta-analysis

Related articles

1. Efficacy and Safety of Treatment Beyond Progression with anti-PD-(L)1 Therapy in Patients with Advanced Non-Small Cell Lung Cancer: A Meta-analysis

   This article has 5 authors:

   1. Jingjun He
   2. Cuiying Chen
   3. Ting Wei
   4. Peng Luo
   5. Jian Zhang

2. Platinum Selection in Immune Checkpoint Inhibitor-Based Therapy for Recurrent or Metastatic Head and Neck Cancer: A Multi-Institutional Retrospective Study

   This article has 8 authors:

   1. JUMPEI YOSHIDA
   2. NAOKI FUKUDA
   3. TAKUMI ITO
   4. KENJI NAKANO
   5. CHIYOE KITAGAWA
   6. HIROKI MITANI
   7. SHUNJI TAKAHASHI
   8. YUJI MIURA

3. Novel Breakthrough in Triple Combination Therapy with Immune Checkpoint Inhibitor, Bevacizumab, and Dose-Reduced Chemotherapy for Patients with Advanced Ovarian Cancer: A Case Series Study

   This article has 6 authors:

   1. Yu Xiang
   2. Wenxin Huang
   3. Jiayi Dong
   4. Yujia Chen
   5. Size Chen
   6. Lijuan Shao